A hypertension medication called olmesartan medoxomil is effective in reversing the narrowing of the arteries that occurs in patients with high blood pressure, according to a new study.
Carlos M. Ferrario, M.D., one of the study’s lead investigators and director of the Hypertension and Vascular Research Center at Wake Forest University Baptist Medical Center, Read the rest of this entry »
A traumatic event is much more likely to result in posttraumatic stress disorder (PTSD) in adults who experienced trauma in childhood - but certain gene variations raise the risk considerably if the childhood trauma involved physical or sexual abuse, scientists have found. The research was conducted with funding from the National Institute of Mental Health, which is part of the National Institutes of Health, Read the rest of this entry »
Women from across the country are making their voices heard on the best ways to care for their bodies, their minds and each other. Their tips? Practice safe sex, get those yearly exams and learn to manage stress.
Through a national women’s health Web site and Brickfish, a social media advertising platform, women are sharing their best health advice through the "The Gift of Giving" Read the rest of this entry »
Many of the 75 million Americans with essential hypertension also develop diabetes and other complications in addition to their high blood pressure, and researchers have discovered a common molecular mechanism in a strain of rat that explains why such metabolic disorders arise together in mammals.
The bioengineering researchers at UC San Diego’s Read the rest of this entry »
For the first time, researchers from the University of Pittsburgh School of Medicine have identified genetic components of dendritic cells that are key to asthma and allergy-related immune response malfunction. Targeting these elements could result in more effective drugs to treat allergic disorders and asthma, according Read the rest of this entry »
Detecting Suicidal Thoughts In Army Vets
11 Jul 2008
University at Buffalo researcher John Violanti, Ph.D., a specialist in suicide among police officers, is preparing to conduct a study on suicide risk among returning veterans. The U.S. Army yesterday reported a "stunning spike" in the number of soldiers taking their own lives.
Violanti currently is testing a computer-based psychological "task" which measures how quickly persons associate feelings of self-harm, as a way of detecting "under the radar" Read the rest of this entry »
Wholesnax Recalls Some Products Because They Contain Soya Lecithin, Which Is Declared As Lecithin, UK
10 Jul 2008
Wholesnax has recalled some batches of its chocolate coated brazils, peanuts, raisins, peanuts and raisins and mixed nuts and raisins because they contain soya lecithin which is declared as lecithin in the ingredients list. The products, therefore, are unsuitable for people with a soya allergy. The Agency has issued an Allergy Alert.
Anyone with a soya allergy is advised not to eat these products. Read the rest of this entry »
Pharmacopeia (Nasdaq:
PCOP), an innovator in the discovery and development of novel small
molecule therapeutics, announced that PS433540, its first-in-class
Dual Acting Receptor Antagonist (DARA), showed statistically significant
blood pressure reductions in a Phase 2a study in patients with mild to
moderate hypertension. PS433540 is being developed Read the rest of this entry »
ISTA Pharmaceuticals Announces New Phase III Clinical Findings To Support Bepreve NDA Filing
09 Jul 2008
ISTA
Pharmaceuticals, Inc. (Nasdaq: ISTA), announced positive results from
the preliminary analysis of its second and final Bepreve(TM) (bepotastine
ophthalmic solution) Phase III clinical study. The U.S. multi-center
conjunctival allergen challenge (CAC) study evaluated the onset and
duration of effect of two Bepreve concentrations in 130 patients with a
history of ocular allergies. Both concentrations demonstrated highly
statistically significant Read the rest of this entry »
Loop diuretics linked to bone loss in older men
09 Jul 2008
Men’s Health News
Older men who take loop diuretics, commonly prescribed drugs for heart failure and hypertension, appear to have increased rates of hip bone loss than men who are not taking this medication, according to a report in the April 14 issue of Archives of Internal Medicine.
"Loop diuretics are one of the most commonly Read the rest of this entry »
AstraZeneca announced a European decentralized procedure (DCP) submission seeking approval for two new dose strengths of Atacand Plus, for those hypertensive patients not optimally controlled by monotherapy. The reference member state for the procedure is Sweden, and the submission incorporates data from three studies. Read the rest of this entry »
People who suffer from severe depression following a heart attack might be more likely to experience cardiac complications while hospitalized, according to a new study.
"There is good evidence that if a person has depression after a heart attack, they are more likely to die from cardiac causes in the following Read the rest of this entry »
Some form of immunotherapy is expected to be available for peanut allergy within the next five years. But the reasons for the increasing prevalence of this allergic reaction remain unclear. The issues are discussed by Professor Wesley Burks, Duke University Medical Center, NC, USA, in a Seminar in this week’s edition of The Lancet.
Peanut allergy has become a major health concern worldwide, especially in developed countries, and affects around Read the rest of this entry »
The nation’s allergists urged a Joint FDA Advisory Committee today to continue to make long-acting beta-2 agonists available for the treatment of moderate-to-severe asthma in appropriate patients.
The Committee recommended the continued availability of long-acting beta-2 agonists Advair (fluticasone propionate and salmeterol) and Symbicort (budesonide/formoterol fumarate dihydrate) but said Serevent (salmeterol xinafoate) and Foradil (formoterol Read the rest of this entry »
Water Released Into The St. Lawrence River Contains Hypertension And Cholesterol Medications
26 Jun 2008
A study conducted by Universit?© de Montr?©al researchers on downstream and upstream water from the Montreal wastewater treatment plant has revealed the presence of chemotherapy products and certain hypertension and cholesterol medications.
Bezafibrate (cholesterol reducing medication), enalapril (hypertension medication), methotrexate and cyclophosphamide (two products used in the treatment Read the rest of this entry »
New ‘Smart’ Materials For The Brain
24 Jun 2008
Research done by scientists in Italy and Switzerland has shown that carbon nanotubes may be the ideal "smart" brain material. Their results, published in the advance online edition of the journal Nature Nanotechnology, are a promising step forward in the search to find ways to "bypass" faulty brain wiring.
The research shows that carbon nanotubes, which, like neurons, are highly Read the rest of this entry »
Huijing Xia, PhD, a postdoctoral research associate in the lab of Eric Lazartigues, PhD, Assistant Professor of Pharmacology at LSU Health Sciences Center New Orleans, is the lead author on a paper reporting that a recently identified enzyme in the brain plays a critically important role in the central regulation of blood pressure. The LSUHSC research team showed that Angiotensin-converting Read the rest of this entry »
NicOx’ Naproxcinod Shows Differentiated 24-Hour Blood Pressure Profile After 13 Weeks Treatment
09 Jun 2008
NicOx S.A. (Euronext Paris: COX) announced positive results from the 112 clinical pharmacology study in 299 patients with osteoarthritis (OA) and hypertension, which was designed to characterize the 24-hour blood pressure profile of naproxcinod in comparison to the two most widely used non-steroidal anti-inflammatory drugs (NSAIDs). Buy Read the rest of this entry »
Awareness, treatment and control of high blood pressure have increased significantly in England.
Rates of blood pressure control have increased to more than 50 percent in men and women.
Controlling blood pressure is one of the most cost-effective ways to reduce the risk of heart attacks, strokes Read the rest of this entry »
Soliris® (eculizumab), a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. (Buy acomplia without prescription Nasdaq: ALXN), reduced blood measures associated with undiagnosed dangerous blood clots and inflammation in patients Read the rest of this entry »
There are few studies comparing the efficacy of short-term psychodynamic psychotherapy (STPP) and pharmacotherapy in major depressive disorder. A group of finnish investigators conducted a comparative study on the efficacy of STPP versus fluoxetine treatment in patients with major depressive disorder in a primary care setting.
Fifty-one patients with major depressive disorder (DSM-IV) of Read the rest of this entry »
Stress during pregnancy can have unfortunate consequences for children born under those conditions - slower development, learning and attention difficulties, anxiety and depressive symptoms and possibly even autism.
That such stress during a mother’s pregnancy can cause developmental and emotional problems for offspring has long been observed by behavioral and biological researchers, but the Read the rest of this entry »
Sanofi-aventis
announced the U.S. Food and Drug Administration (FDA) has approved
Nasacort AQ Nasal Spray (triamcinolone acetonide) for children aged 2 - 5
years old for the treatment of nasal symptoms associated with seasonal and
perennial allergic rhinitis.
The FDA based its approval on the results of a multicenter, randomized,
double-blind, placebo-controlled study demonstrating that Nasacort Read the rest of this entry »
The level of knowledge and understanding of children with food allergies varies significantly across three key groups: pediatricians and family physicians, the general public and families who have a child with food allergies. The article describing the new findings was published in the September issue of BioMed Central Pediatrics.
The research group, led by Ruchi Gupta, MD MPH, assistant professor of pediatrics at Northwestern Read the rest of this entry »
Sciele Pharma, Inc., a Shionogi Company, today announced that Addrenex Pharmaceuticals, Inc. has initiated its Phase II clinical trial with ADX415 for the treatment of hypertension. generic viagra online buy This is a multicenter, double-blind, randomized, placebo-controlled, dose-ranging study that will involve 80 patients. ADX415 is a novel, patented, centrally Read the rest of this entry »